title: Rules for evaluating biosimilars put applicants through hoops.
authors.affiliation: Genentech, USA. TMorrow@ManagedCareMag.com
authors.forename: Thomas
authors.initials: T
authors.lastname: Morrow
mesh_terms: D001688:Biological Products / Q000191:economics / Q000592:standards*; D004345:Drug Industry / Q000191:economics; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D004465:Economic Competition; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001688:Biological Products